Company / Assets per Share
4D Molecular Therapeutics, Inc. Assets per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$12.38
FY2025
5-year range
$8.13 / $13.25
FY2021-FY2025
Trend
-4.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $10.42 to $12.38 over the past 2 years.
Based on SEC 10-K filings.
12.38 in FY2025 with a 5-year CAGR of -26.0%.
Improved from $10.42 to $12.38 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +15.1%
- 5-Year CAGR
- -26.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, assets per share decreased 4.9% year-over-year.
- Peak assets per share was recorded in FY2020.
- Lowest assets per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.26 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.38 | -4.9% |
| FY2024 | $13.01 | +24.9% |
| FY2023 | $10.42 | +28.2% |
| FY2022 | $8.13 | -38.7% |
| FY2021 | $13.25 | -76.2% |
| FY2020 | $55.67 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026